2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Multiple Myeloma
2
Depression
2
Breast Neoplasms
2
Anxiety Disorders
2
Uveal Melanoma
1
Small Cell Lung Carcinoma
1
Prolactin-Producing Pituitary Tumor
1
Pituitary ACTH Hypersecretion
1
Neoplasms
1
Neoplasm Metastasis
1
Metastatic Solid Tumor Cancers
1
Lung Neoplasms
1
Glioma
1
Glioblastoma
1
Cushing Syndrome
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Cancer Caregivers
1
Interventions
Carboplatin
346
Cisplatin
240
Paclitaxel
208
Radiotherapy
207
Pemetrexed
190
Docetaxel
170
Gemcitabine
158
pembrolizumab
147
Erlotinib Hydrochloride
111
Magnetic Resonance Spectroscopy
102
Etoposide
99
Bevacizumab
96
Specimen Handling
84
Nivolumab
77
Radiosurgery
74
durvalumab
73
Blood Specimen Collection
65
Drug Therapy
61
osimertinib
56
Vinorelbine
54
Gefitinib
50
Surveys and Questionnaires
48
atezolizumab
45
Biopsy
43
Radiation
42
Irinotecan
42
Topotecan
39
Standard of Care
39
Cyclophosphamide
38
Surgical Procedures, Operative
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
4-amino-4'-hydroxylaminodiphenylsulfone
×
Clear all
NCT07243132
2026-04-27
LUNGEVITY
Groupe Francais De Pneumo-Cancerologie
Recruiting
1,000 enrolled